Agents , 2009, vol
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
Its mechanism involves stimulating blood vessel growth and tissue regeneration
Usage Pharmaceutical Packaging, Penicilline, Freeze-Dried Powder, Vitamin Product Name Amber Vitamin B12 Tubular Medicine Glass Injection Surface Handling Frosted, Spray Painting, Silk Screen, Decal, Label Caps Butyl Coated Sterilize Rubber Stopper Logo Printing Without Logo Printing Application Pharmaceutical Transport Package Carton or Pallet Specification 5ml 6ml 8ml 10ml 15ml Production Capacity 20000000 Pieces Product Description Amber Vitamin b12 Tubular Medicine Glass Injection Vials Bottles Size: 5ml, 6ml, 8ml, 10ml, 15ml, customer's requiremetns
